Status of work in February
In February, AOTMiT begins work on orders from the Minister of Health:
- Bupropion Neuraxpharm (bupropion hydrochloride) for the treatment of major depressive episodes
- Skyrizi (risankizumab) for the treatment of patients with Crohn’s disease
The listed order is available on the AOTMiT Public Information Bulletin.